The market dynamics for Anaplastic Lymphoma Kinase-positive Non-Small Cell Lung Cancer (ALK-positive NSCLC) are witnessing ...
Portable, cartridge-based multiplex systems, digital integration, and expansion into oncology and remote care drive point-of-care molecular diagnostics adoption.Dublin, Oct. (GLOBE NEWSWIRE) -- "Point ...
Capitalize on GLP-1 monitoring, clinical-grade BIA, connected care and direct-sales support as demand shifts beyond BMI to fat, muscle and sarcopenia assessmentDublin, Oct. (GLOBE NEWSWIRE) -- "Body ...
According to DelveInsight's analysis, the chondrosarcoma market size was found to be ~USD 15 million in the 7MM in 2025, and it is projected to grow at a CAGR of 16% during 2026–2036. Among the 7MM, ...